World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Zhao XY, Yu SY, Da SP, Bai L, Guo XZ, Dai XJ, Wang YM. A clinical evaluation of serological diagnosis for pancreatic cancer. World J Gastroenterol 1998; 4(2): 147-149 [PMID: 11819260 DOI: 10.3748/wjg.v4.i2.147]
URL:	https://www.wjgnet.com/1007-9327/full/v4/i2/147.htm

(0) (0) (0) (3686) (27)

Number	Citing Articles
1	Dong WU, Jia Ming QIAN, Rui Xue DENG, Wei Jun JIANG, Yuan Jia CHEN, Xiao Hong LIU, Xing Hua LU. Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer. Chinese Journal of Digestive Diseases 2006; 7(2) doi: 10.1111/j.1443-9573.2006.00249.x
2	Xing-Lei Qin, Zuo-Ren Wang, Jing-Sen Shi, Min Lu, Lin Wang, Quan-Ru He. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA. World Journal of Gastroenterology 2004; 10(3): 427-432 doi: 10.3748/wjg.v10.i3.427 Abstract(1521) \| Core Tip(1095) \| Full Article(HTML)(6583) \| Full Article (PDF)-132K(844) \| Times Cited (140) \| Total Visits (8468) \| Open
3	Jonathan M. Oyler, Bao Q. Tran, David P. A. Kilgour. Rapid Denaturing Organic Digestion Method for Targeted Protein Identification and Characterization. Analytical Chemistry 2021; 93(12) doi: 10.1021/acs.analchem.0c04143
4	Tsann‐Long Hwang, Ying Liang, Kuan‐Yi Chien, Jau‐Song Yu. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma. PROTEOMICS 2006; 6(7) doi: 10.1002/pmic.200500345
5	Antonio Moral, José Magarzo. Marcadores tumorales serológicos en cirugía hepatobiliopancreática. Cirugía Española 2004; 76(5) doi: 10.1016/S0009-739X(04)72378-7
6	George Vasiliades, Nikolaos Kopanakis, Michalis Vasiloglou, George Zografos, Helias Margaris, Kyriaki Masselou, Evniki Kokosi, Theodore Liakakos. Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancer. The International Journal of Biological Markers 2012; 27(3) doi: 10.5301/JBM.2012.9348
7	Jun-Ming Guo, Bing-Xiu Xiao, De-Jian Dai, Qiong Liu, Hong-Hui Ma. Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells <i>in vitro</i>. World Journal of Gastroenterology 2004; 10(6): 860-863 doi: 10.3748/wjg.v10.i6.860 Abstract(1380) \| Core Tip(1147) \| Full Article(HTML)(3712) \| Full Article (PDF)-166K(451) \| Times Cited (44) \| Total Visits (4634) \| Open
8	Lane C. Patten, David H. Berger. Role of Proteases in Pancreatic Carcinoma. World Journal of Surgery 2005; 29(3) doi: 10.1007/s00268-004-7816-3
9	Felix Rückert, Christian Pilarsky, Robert Grützmann. Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries. Cancers 2010; 2(2) doi: 10.3390/cancers2021107
10	E. Coban, M. Samur, H. Bozcuk, M. Ozdogan. The Value of CEA and CA 19-9 in Detecting Cancer in a Group of High-Risk Subjects with Gastrointestinal Symptoms. The International Journal of Biological Markers 2003; 18(3) doi: 10.1177/172460080301800304
11	Jiehua Lin, Feng Yan, Xiaoya Hu, Huangxian Ju. Chemiluminescent immunosensor for CA19-9 based on antigen immobilization on a cross-linked chitosan membrane. Journal of Immunological Methods 2004; 291(1-2) doi: 10.1016/j.jim.2004.06.001
12	X.G. Ni, X.F. Bai, Y.L. Mao, Y.F. Shao, J.X. Wu, Y. Shan, C.F. Wang, J. Wang, Y.T. Tian, Q. Liu, D.K. Xu, P. Zhao. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. European Journal of Surgical Oncology (EJSO) 2005; 31(2) doi: 10.1016/j.ejso.2004.09.007
13	Mohamed M. Abdel-Aziz, Mahmoud Lotfy, Ibrahim M. El-Kady, Mostafa Abozaid. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor. Cancer Detection and Prevention 2009; 32(4) doi: 10.1016/j.cdp.2005.10.006
14	Fangfeng Liu, Futian Du, Xiao Chen. Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer. World Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-333
15	Chi-Ying Yang, Ro-Ting Lin, Chi-Yi Chen, Chun-Chieh Yeh, Chao-Ming Tseng, Wen-Hsin Huang, Teng-Yu Lee, Chia-Shen Chu, Jaw-Town Lin. Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma. Journal of the Formosan Medical Association 2022; 121(12) doi: 10.1016/j.jfma.2022.07.003
16	Yang Tang, Yidi Cui, Shufeng Zhang, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Progress in Molecular Biology and Translational Science 2019; 162 doi: 10.1016/bs.pmbts.2019.01.010
17	B.C. Visser, V.R. Muthusamy, B.M. Yeh, F.V. Coakley, L.W. Way. Diagnostic evaluation of cystic pancreatic lesions. HPB 2008; 10(1) doi: 10.1080/13651820701883155
18	Zhang-Qing Zheng, Yu-Long He, Dong-Ping Wang, Dong Zheng, Ji-Zong Zhao, Wen-Hua Zhan, Chao-Xu Zheng. Prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer. World Journal of Gastroenterology 2001; 7(3): 431-434 doi: 10.3748/wjg.v7.i3.431 Abstract(1445) \| Core Tip(1061) \| Full Article(HTML)(5069) \| Full Article (PDF)-67K(617) \| Times Cited (45) \| Total Visits (6616) \| Open
19	Min Zheng, Lian-Xin Liu, An-Long Zhu, Shu-Yi Qi, Hong-Chi Jiang, Zhu-Ying Xiao. <i>K-ras</i> gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses. World Journal of Gastroenterology 2003; 9(1): 188-191 doi: 10.3748/wjg.v9.i1.188 Abstract(1273) \| Core Tip(1143) \| Full Article(HTML)(3030) \| Full Article (PDF)-92K(375) \| Times Cited (13) \| Total Visits (3912) \| Open
20	Xiaozhong Guo, Zhongmin Cui. Current Diagnosis and Treatment of Pancreatic Cancer in China. Pancreas 2005; 31(1) doi: 10.1097/01.mpa.0000168220.97967.d1
21	Jens Koopmann, C. Nicole White Rosenzweig, Zhen Zhang, Marcia I. Canto, David A. Brown, Mark Hunter, Charles Yeo, Daniel W. Chan, Samuel N. Breit, Michael Goggins. Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9. Clinical Cancer Research 2006; 12(2) doi: 10.1158/1078-0432.CCR-05-0564
22	MASAHIRO TANAKA, NOBUKAZU KOMATSU, YASUAKI YANAGIMOTO, MASAO OKA, SHIGEKI SHICHIJO, SEIYA OKUDA, KYOGO ITOH. Development of a New Diagnostic Tool for Pancreatic Cancer: Simultaneous Measurement of Antibodies against Peptides Recognized by Cytotoxic T Lymphocytes. The Kurume Medical Journal 2006; 53(3/4) doi: 10.2739/kurumemedj.53.63
23	Chunlin Ge, Ning Ma, Dianbo Yao, Fengming Luan, Chaojun Hu, Yongzhe Li, Yongfeng Liu. A serum Biomarker model to diagnose pancreatic cancer using proteomic fingerprint technology. Chinese Journal of Clinical Oncology 2008; 5(3) doi: 10.1007/s11805-008-0200-6
24	Li-Nan Ren, Jia-Jun Zhao, Zhong-Min Cui, Hong-Yu Li, Di Wang, Jian-Hua Xu, Xiao-Zhong Guo, Min-Pei Liu. New tumor-associated antigen SC6 in pancreatic cancer. World Journal of Gastroenterology 2005; 11(48): 7671-7675 doi: 10.3748/wjg.v11.i48.7671 Abstract(1374) \| Core Tip(970) \| Full Article(HTML)(2580) \| Full Article (PDF)-682K(317) \| Times Cited (4) \| Total Visits (3371) \| Open
25	Ying-Nai Wang, Heng-Huan Lee, Mien-Chie Hung. A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases. Journal of Biomedical Science 2018; 25(1) doi: 10.1186/s12929-018-0484-7
26	Dan Du, Feng Yan, Shengli Liu, Huangxian Ju. Immunological assay for carbohydrate antigen 19-9 using an electrochemical immunosensor and antigen immobilization in titania sol–gel matrix. Journal of Immunological Methods 2003; 283(1-2) doi: 10.1016/j.jim.2003.08.014
27	Ning Ma, Chun-lin Ge, Feng-ming Luan, Dian-bo Yao, Chao-jun Hu, Ning Li, Yong-feng Liu. Serum protein fingerprint of patients with pancreatic cancer by SELDI technology. Chinese Journal of Cancer Research 2008; 20(3) doi: 10.1007/S11670-008-0171-4